Landscape of Measurable Residual Disease in Acute Myeloid Leukemia: From Molecular Detection to Clinical Practice
Medical Sciences · 05.03.2026 · 14 (1) · 123
DOI: 10.3390/medsci14010123 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medical Sciences, online erschienen am 05.03.2026. Verfasst von Mohammad Shahzaib Qadir und 1 weiteren Autor:innen. Beteiligte Einrichtung: Medical College, Aga Khan University, Karachi 74200, Pakistan. Hauptthemen laut MEDLINE: Neoplasm, Residual, Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Measurable residual disease (MRD) has become a central determinant of prognosis and treatment planning in acute myeloid leukemia (AML). MRD assessment is now aided by a wide range of technologies, including next-generation sequencing, PCR-based assays, multiparameter flow cytometry, and emerging approaches such as liquid biopsy platforms and imaging-based detection. These modalities differ in sensitivity, applicability, and interpretive framework, yet each offers distinct advantages in specific disease contexts. Beyond technical issues, MRD is becoming increasingly integrated into clinical practice. In non-intensive treatment settings, where targeted and low-intensity regimens rely on dynamic disease monitoring to guide ongoing management, MRD is increasingly being used to inform therapeutic decisions. In the peri-transplant setting, MRD status influences conditioning strategies, donor selection, and the use of post-transplant interventions. Despite the growing evidence supporting the clinical relevance of MRD across these scenarios, challenges remain regarding standardization, optimal timing of assessment, and the interpretation of discordant results. This review summarizes the full landscape of MRD detection methods and examines the evolving role of MRD in contemporary AML management, emphasizing current applications and areas requiring further refinement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical College, Aga Khan University, Karachi 74200, Pakistan.
- Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
ORCID-Profile: Mohammad Shahzaib Qadir, Omer Jamy
Zitieren
APA
Qadir, M. S., & Jamy, O. (2026). Landscape of Measurable Residual Disease in Acute Myeloid Leukemia: From Molecular Detection to Clinical Practice. Medical Sciences, 14(1), 123. https://doi.org/10.3390/medsci14010123
Vancouver
Qadir MS, Jamy O. Landscape of Measurable Residual Disease in Acute Myeloid Leukemia: From Molecular Detection to Clinical Practice. Medical Sciences. 2026;14(1):123. doi:10.3390/medsci14010123
BibTeX
@article{Qadir2026,
author = {Qadir, Mohammad Shahzaib and Jamy, Omer},
title = {Landscape of Measurable Residual Disease in Acute Myeloid Leukemia: From Molecular Detection to Clinical Practice},
journal = {Medical Sciences},
year = {2026},
volume = {14},
number = {1},
pages = {123},
doi = {10.3390/medsci14010123}
}
EUVIMED